KURLAND FRED (Chief Financial Officer) exercised options at ARIDIS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/15/2023ACC: 0001493152-23-021470
Officer· Chief Financial Officer
Since Aug 2018
+10K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
14K acquired · 4K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4K
Price / share
—
Trade value
—
% of position
New position
6/5/2023
0.00→4K
Total
Net shares
+4K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2023 | M · Option Exercise | +4K | — | — | New position | 0.00 | 4K |
| Total | +4K | $0.00 | ||||||
Derivative Transactions2
Stock Options
Direct
Converts to
Common Stock
10K shares
Shares
+10K
Strike price
0.16
Held after
84.58K
Exercisable
—
5/4/2023
Restricted Stock Units
Direct
Converts to
Common Stock
4K shares
Shares
−4K
Strike price
Held after
4K
Exercisable
—
6/5/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock10K shares | 5/4/2023 | A · Award | +10K | 0.16 | — | 84.58K |
| Restricted Stock Units Direct | Common Stock4K shares | 6/5/2023 | M · Option Exercise | −4K | — | 4K |